833 related articles for article (PubMed ID: 24796766)
1. A randomized, controlled, pilot trial on the effect of dehydroepiandrosterone on ovarian response markers, ovarian response, and in vitro fertilization outcomes in poor responders.
Yeung TW; Chai J; Li RH; Lee VC; Ho PC; Ng EH
Fertil Steril; 2014 Jul; 102(1):108-115.e1. PubMed ID: 24796766
[TBL] [Abstract][Full Text] [Related]
2. A double-blind randomised controlled trial on the effect of dehydroepiandrosterone on ovarian reserve markers, ovarian response and number of oocytes in anticipated normal ovarian responders.
Yeung T; Chai J; Li R; Lee V; Ho PC; Ng E
BJOG; 2016 Jun; 123(7):1097-105. PubMed ID: 26663817
[TBL] [Abstract][Full Text] [Related]
3. 450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial.
Lefebvre J; Antaki R; Kadoch IJ; Dean NL; Sylvestre C; Bissonnette F; Benoit J; Ménard S; Lapensée L
Fertil Steril; 2015 Dec; 104(6):1419-25. PubMed ID: 26361207
[TBL] [Abstract][Full Text] [Related]
4. A randomized double-blinded placebo-controlled trial on the effect of dehydroepiandrosterone for 16 weeks on ovarian response markers in women with primary ovarian insufficiency.
Yeung TW; Li RH; Lee VC; Ho PC; Ng EH
J Clin Endocrinol Metab; 2013 Jan; 98(1):380-8. PubMed ID: 23144466
[TBL] [Abstract][Full Text] [Related]
5. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
[TBL] [Abstract][Full Text] [Related]
6. A prospective study on role of dehydroepiandrosterone (DHEA) on improving the ovarian reserve markers in infertile patients with poor ovarian reserve.
Singh N; Zangmo R; Kumar S; Roy KK; Sharma JB; Malhotra N; Vanamail P
Gynecol Endocrinol; 2013 Nov; 29(11):989-92. PubMed ID: 24004296
[TBL] [Abstract][Full Text] [Related]
7. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.
Lan VT; Linh NK; Tuong HM; Wong PC; Howles CM
Reprod Biomed Online; 2013 Oct; 27(4):390-9. PubMed ID: 23953069
[TBL] [Abstract][Full Text] [Related]
8. Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients.
Arce JC; La Marca A; Mirner Klein B; Nyboe Andersen A; Fleming R
Fertil Steril; 2013 May; 99(6):1644-53. PubMed ID: 23394782
[TBL] [Abstract][Full Text] [Related]
9. Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial.
Nyboe Andersen A; Nelson SM; Fauser BC; García-Velasco JA; Klein BM; Arce JC;
Fertil Steril; 2017 Feb; 107(2):387-396.e4. PubMed ID: 27912901
[TBL] [Abstract][Full Text] [Related]
10. Is the modified natural in vitro fertilization cycle justified in patients with "genuine" poor response to controlled ovarian hyperstimulation?
Kedem A; Tsur A; Haas J; Yerushalmi GM; Hourvitz A; Machtinger R; Orvieto R
Fertil Steril; 2014 Jun; 101(6):1624-8. PubMed ID: 24680364
[TBL] [Abstract][Full Text] [Related]
11. The effect of dehydroepiandrosterone supplementation on ovarian response is associated with androgen receptor in diminished ovarian reserve women.
Hu Q; Hong L; Nie M; Wang Q; Fang Y; Dai Y; Zhai Y; Wang S; Yin C; Yang X
J Ovarian Res; 2017 May; 10(1):32. PubMed ID: 28472976
[TBL] [Abstract][Full Text] [Related]
12. The addition of anti-Müllerian hormone in an algorithm for individualized hormone dosage did not improve the prediction of ovarian response-a randomized, controlled trial.
Magnusson Å; Nilsson L; Oleröd G; Thurin-Kjellberg A; Bergh C
Hum Reprod; 2017 Apr; 32(4):811-819. PubMed ID: 28175316
[TBL] [Abstract][Full Text] [Related]
13. Using the ovarian sensitivity index to define poor, normal, and high response after controlled ovarian hyperstimulation in the long gonadotropin-releasing hormone-agonist protocol: suggestions for a new principle to solve an old problem.
Huber M; Hadziosmanovic N; Berglund L; Holte J
Fertil Steril; 2013 Nov; 100(5):1270-6. PubMed ID: 23931964
[TBL] [Abstract][Full Text] [Related]
14. Dehydroepiandrosterone administration before IVF in poor responders: a prospective cohort study.
Vlahos N; Papalouka M; Triantafyllidou O; Vlachos A; Vakas P; Grimbizis G; Creatsas G; Zikopoulos K
Reprod Biomed Online; 2015 Feb; 30(2):191-6. PubMed ID: 25498594
[TBL] [Abstract][Full Text] [Related]
15. Does dehydroepiandrosterone supplementation really affect IVF-ICSI outcome in women with poor ovarian reserve?
Kara M; Aydin T; Aran T; Turktekin N; Ozdemir B
Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():63-5. PubMed ID: 24331115
[TBL] [Abstract][Full Text] [Related]
16. Does metformin affect the ovarian response to gonadotropins for in vitro fertilization treatment in patients with polycystic ovary syndrome and reduced ovarian reserve? A randomized controlled trial.
Palomba S; Falbo A; Di Cello A; Cappiello F; Tolino A; Zullo F
Fertil Steril; 2011 Nov; 96(5):1128-33. PubMed ID: 21917254
[TBL] [Abstract][Full Text] [Related]
17. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
[TBL] [Abstract][Full Text] [Related]
18. Ethnicity as a determinant of ovarian reserve: differences in ovarian aging between Spanish and Indian women.
Iglesias C; Banker M; Mahajan N; Herrero L; Meseguer M; Garcia-Velasco JA
Fertil Steril; 2014 Jul; 102(1):244-9. PubMed ID: 24794314
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Dehydroepiandrosterone (DHEA) to overcome the effect of ovarian ageing (DITTO): A proof of principle double blinded randomized placebo controlled trial.
Narkwichean A; Maalouf W; Baumgarten M; Polanski L; Raine-Fenning N; Campbell B; Jayaprakasan K
Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():39-48. PubMed ID: 28934714
[TBL] [Abstract][Full Text] [Related]
20. Predictors of ovarian response in women treated with corifollitropin alfa for in vitro fertilization/intracytoplasmic sperm injection.
Polyzos NP; Tournaye H; Guzman L; Camus M; Nelson SM
Fertil Steril; 2013 Aug; 100(2):430-7. PubMed ID: 23668992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
